Skip to main content

Table 1 Clinical characteristics of controls and patients who survived sepsis

From: Sepsis-induced long-term immune paralysis – results of a descriptive, explorative study

  Control (n = 8) Sepsis (n = 8)
Age, median (range) 59 (34–85) 60 (36–82
Male sex 5 (62.5) 5 (62.5)
Body mass index, kg/m2, median (range) 26.4 (18.1–34.3) 24.4 (22.2–40.4)
Time since sepsis, months, median (range)   26 (9–52)
Infection focus responsible for sepsis   
Urogenital   4 (50)
necrotizing fasciitis   2 (25)
Pulmonary   1 (12.5)
Endoprothesis infection   1 (12.5)
Morbidities (current and past)   
Heart and circulation   
Myocardial infarction 2 (25) 2 (25)
Myocarditis 0 (0) 0 (0)
Stroke 1 (12.5) 0 (0)
Pulmonary artery embolism 0 (0) 0 (0)
Thrombosis 0 (0) 0 (0)
Airway and lung   
Asthma 0 (0) 0 (0)
chronic bronchitis 0 (0) 2 (25)
Pneumonia 0 (0) 2 (25)
Exacerbation of chronic obstructive pulmonary disease 0 (0) 1 (12.5)
Kidney   
Insufficiency 1 (12.5) 1 (12.5)
Pyelonephritis 0 (0) 1 (12.5)
Glomerulonephritis 0 (0) 0 (0)
Gastrointestinal tract and metabolism   
Chronic inflammatory bowel disease 0 (0) 0 (0)
Ulcus 0 (0) 1 (12.5)
Gastritis 1 (12.5) 1 (12.5)
Diabetes 3 (37.5) 3 (37.5)
Current medications 6 (75) 7 (87.5)
Anticoagulants 0 (0) 3 (37.5)
Anti-platelet agents 5 (62.5) 3 (37.5)
Antihypertensive medication 2 (25) 5 (62.5)
Diuretics 1 (12.5) 4 (50)
Diabetes medication 3 (37.5) 3 (37.5)
Insulin 2 (25) 3 (37.5)
  1. Absolute number (percentage), if not otherwise specified